Early Phase 1 Oesophageal Cancer Trial, Recruiting NCT06824363 Sponsor: University of California, Irvine Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Early Phase 1 Oesophageal Cancer Trial, Recruiting

NCT06824363
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have cancer of the esophagus or stomach (including cases that cannot be surgically removed) that has not spread to other parts of the body
  • People who have not yet received any treatment for this cancer
  • People whose cancer has been confirmed by a laboratory test to be a specific type called adenocarcinoma, and whose cancer has a specific genetic change called an ARID1a mutation, detected through either a blood test or a tissue sample test
  • People whose cancer has been tested and shown to be "MSI-Stable" or "pMMR" — meaning it has a particular genetic profile (confirm with trial site for what this means for eligibility)
  • People aged 18 or older
  • People who weigh more than 66 pounds (approximately 30 kg)
  • People who are reasonably active and able to care for themselves, based on a standard medical scoring system called ECOG, with a score of 2 or less (confirm with trial site)
  • People for whom it is medically possible to have a repeat biopsy (a procedure to take a small tissue sample)
  • People who do not have a significant autoimmune disease (a condition where the immune system mistakenly attacks the body)

Who may not be able to join:

  • People whose cancer has already spread to other parts of the body (metastatic disease)
  • People who have previously received any systemic treatment (such as chemotherapy or other medicines that work throughout the body) for esophagus, stomach, or gastroesophageal junction cancer
  • People who have an autoimmune disease that is not well controlled, as determined by the trial doctor
  • People who are unable or unwilling to undergo biopsy procedures to provide tissue samples for the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Farshid Dayyani, Chao Family Comprehensive Cancer Center

Phone: 1-877-827-8839

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
University of California, Irvine
Registry
ClinicalTrials.gov
Start date
25 May 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of Subjects Completing Study Treatment; Percentage of Subjects Completing Post-Treatment Biopsy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov